Bridget Martell on taking Yale spinout ‘to adulthood’; Cullinan Oncology CEO announces resignation as Bristol Myers hematology exec is welcomed aboard

Bridget Martell

Bridget Martell’s first clinical trial was an unorthodox one.

Then a resident in internal medicine at Yale, she was given an award to explore a career in clinical research — which was how she wound up leading a Phase I study for a therapeutic...

Click to view original post